1-3 of 3
Philip A. Lowry, MD
Close
Sort by
Journal Articles

Antileukemic Activity of Shepherdin, a Novel Targeted Inhibitor of the Survivin-Hsp90 Complex.

Boglarka Gyurkocza, MD, Janet Plescia, Madhavi Toke, MD, Dale Greiner, PhD, Giorgio Colombo, PhD, Philip A. Lowry, MD, Dario C. Altieri, MD
Journal: Blood
Blood (2005) 106 (11): 242.
https://doi.org/10.1182/blood.V106.11.242.242
Published: 2005
Journal Articles

In Vivo Chemotherapy Protection and Efficacy of Multidrug Resistance (MDR-1) Gene Transfer in a Patient with Refractory Non-Hodgkin’s Lymphoma (NHL).

Pamela S. Becker, MD, PhD, Adrianne N. Hanks, BA, Ying Ping Yu, MD, Ann Marie Ceredona, MT(ASCP), MA, William V. Walsh, MD, Judith L. O’Donnell, BS, Christopher Baum, MD, Lynn Kallander, MT(ASCP), BS, Philip A. Lowry, MD, T.J. Fitzgerald, MD, Peter Westervelt, MD, PhD, F. Marc Stewart, MD
Journal: Blood
Blood (2005) 106 (11): 3054.
https://doi.org/10.1182/blood.V106.11.3054.3054
Published: 2005
Journal Articles

Transfer of the Multidrug Resistance Gene, MDR-1, to Hematopoietic Progenitors from a Patient with Transformed Large Cell Lymphoma, and Demonstration of In Vivo Chemotherapy Protection with Dose Escalating Chemotherapy.

Pamela S. Becker, MD, PhD, Ying Ping Yu, MD, Ann Marie Ceredona, MT, MA, William V. Walsh, MD, Judith L. O’Donnell, BS, RN, Christopher Baum, MD, Lynn Kallander, BS, Philip A. Lowry, MD, T. J. Fitzgerald, MD, Peter Westervelt, MD, PhD, F. Marc Stewart, MD
Journal: Blood
Blood (2004) 104 (11): 5278.
https://doi.org/10.1182/blood.V104.11.5278.5278
Published: 2004